0.234

0.43% 0.001

After Hours: .24 0.006 +2.56%

Matinas Biopharma Holdings Inc (MTNB)

Overview News Price History Discussions Forecast

Matinas Biopharma Holdings Inc stock is traded at $0.234, with a volume of 2.39M. It is up +0.43% in the last 24 hours and down -33.10% over the past month. Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company enables the delivery of life-changing medicines using its lipid nano-crystal (LNC) platform technology. Its LNC delivery technology platform utilizes lipid nano-crystals which can encapsulate small molecules, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. The company's lead anti-fungal product candidate is MAT2203, an orally-administered cochleate formulation of amphotericin B that has completed Phase II clinical trials for the prevention of invasive fungal infections due to immunosuppressive therapy in patients with acute lymphoblastic leukemia. Its product candidates also comprise MAT2501, an orally administered cochleate formulation of the broad spectrum aminoglycoside antibiotic amikacin that has completed Phase I clinical trials to treat various types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections, as well as various multidrug-resistant gram negative and intracellular bacterial infections. The company was founded in 2013 and is based in Bedminster, New Jersey.

Previous Close:

$0.233

Open:

$0.2387

24h Volume:

2.39M

Relative Volume:

0.57

Market Cap:

$1.50M

Revenue:

$1.10M

Net Income/Loss:

$-11.23M

P/E Ratio:

-0.1156

EPS:

-2.025

Net Cash Flow:

$-6.61M

1W Performance:

-17.31%

1M Performance:

-33.10%

6M Performance:

-60.35%

1Y Performance:

-85.82%

1-Day Range:

$0.2216

$0.25

1-Week Range:

$0.2216

$0.28

52-Week Range:

$0.2216

$3.09

Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile

Name

Matinas Biopharma Holdings Inc

Sector

Healthcare (1080)

Industry

Biotechnology (604)

Phone

908-443-1860

Address

1545 Route 206 South, Suite 302, Bedminster, NJ

Employee

Twitter

@MatinasBio

Next Earnings Date

2026-08-13

Latest SEC Filings

MTNB's Discussions on Twitter

Compare MTNB vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MTNB Matinas Biopharma Holdings Inc	0.234	1.54M	1.10M	-11.23M	-6.61M	-2.025
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-11-21	Downgrade	Piper Sandler	Overweight → Neutral
Aug-26-20	Resumed	Piper Sandler	Overweight
Jan-27-20	Initiated	Piper Sandler	Overweight
Jan-24-20	Initiated	SunTrust	Buy
Jan-23-20	Initiated	SunTrust	Buy
Jan-09-20	Initiated	Aegis Capital	Buy
Jun-26-19	Initiated	H.C. Wainwright	Buy

View All

Matinas Biopharma Holdings Inc Stock (MTNB) Latest News

Aug 13, 2026

Matinas BioPharma (MTNB) holder Adam Stern details 9.99% stake and new warrants - Stock Titan

Aug 13, 2026

Aug 10, 2026

US Micro Cap StocksInvest from India - INDmoney

Aug 10, 2026